{"id":"https://openalex.org/W2558094369","doi":"https://doi.org/10.1182/blood.v112.11.2150.2150","title":"Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.","display_name":"Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2558094369","doi":"https://doi.org/10.1182/blood.v112.11.2150.2150","mag":"2558094369"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.2150.2150","doi":"https://doi.org/10.1182/blood.v112.11.2150.2150","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.2150.2150","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065589058","display_name":"Shin Mineishi","orcid":"https://orcid.org/0000-0001-7565-7080","observed_orcids":["https://orcid.org/0000-0001-7565-7080"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shin Mineishi","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009204664","display_name":"John Martin Magenau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Magenau","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012489403","display_name":"Attaphol Pawarode","orcid":"https://orcid.org/0000-0001-6323-9623","observed_orcids":["https://orcid.org/0000-0001-6323-9623"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Attaphol Pawarode","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112233750","display_name":"T. Buck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Buck","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104039770","display_name":"Dawn M. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dawn Jones","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028379115","display_name":"Koji Kato","orcid":"https://orcid.org/0000-0002-5815-4585","observed_orcids":["https://orcid.org/0000-0002-5815-4585"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koji Kato","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020392728","display_name":"David G. Frame","orcid":"https://orcid.org/0000-0001-5679-9868","observed_orcids":["https://orcid.org/0000-0001-5679-9868"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Frame","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007485660","display_name":"Lisa A. Kujawski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Kujawski","raw_affiliation_strings":["Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050556099","display_name":"Harry Paul Erba","orcid":"https://orcid.org/0000-0003-1093-2189","observed_orcids":["https://orcid.org/0000-0003-1093-2189"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry Paul Erba","raw_affiliation_strings":["Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109814710","display_name":"Yasser A. Khaled","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasser Khaled","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113060248","display_name":"Edward M. Peres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward M. Peres","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109186862","display_name":"Oleg I. Krijanovski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oleg I. Krijanovski","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078441495","display_name":"Pavan R. Reddy","orcid":"https://orcid.org/0000-0001-7264-8429","observed_orcids":["https://orcid.org/0000-0001-7264-8429"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pavan Reddy","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069466344","display_name":"Carrie Lynn Kitko","orcid":"https://orcid.org/0000-0001-9216-2901","observed_orcids":["https://orcid.org/0000-0001-9216-2901"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie Kitko","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103081510","display_name":"Sung Won Choi","orcid":"https://orcid.org/0000-0002-2043-4565","observed_orcids":["https://orcid.org/0000-0002-2043-4565"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sung Choi","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084871192","display_name":"Gregory Anthony Yanik","orcid":"https://orcid.org/0000-0003-3829-4940","observed_orcids":["https://orcid.org/0000-0003-3829-4940"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory A. Yanik","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030368112","display_name":"Thomas W Braun","orcid":"https://orcid.org/0000-0002-6165-4804","observed_orcids":["https://orcid.org/0000-0002-6165-4804"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Braun","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023099227","display_name":"James L.M. Ferrara","orcid":"https://orcid.org/0000-0001-8595-3940","observed_orcids":["https://orcid.org/0000-0001-8595-3940"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L.M. Ferrara","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043877705","display_name":"John E. Levine","orcid":"https://orcid.org/0000-0002-5611-7828","observed_orcids":["https://orcid.org/0000-0002-5611-7828"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John E. Levine","raw_affiliation_strings":["Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.0779,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.80262771,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"2150","last_page":"2150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clofarabine","display_name":"clofarabine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.9800000190734863},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.8790000081062317},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.8569999933242798},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8529999852180481},{"id":"https://openalex.org/keywords/refractory-hematologic-malignancies","display_name":"refractory hematologic malignancies","score":0.8029999732971191},{"id":"https://openalex.org/keywords/engraftment","display_name":"engraftment","score":0.6489999890327454},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7239999771118164},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.6729999780654907},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9300000071525574},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.777999997138977},{"id":"https://openalex.org/keywords/capillary-leak","display_name":"capillary leak syndrome","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2777198975","wikidata":"https://www.wikidata.org/wiki/Q5134875","display_name":"Clofarabine","level":4,"score":0.9782074689865112},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7719283103942871},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.7524569034576416},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.6888348460197449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6188544034957886},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5297005772590637},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.502089262008667},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.4392854869365692},{"id":"https://openalex.org/C2777630719","wikidata":"https://www.wikidata.org/wiki/Q21006907","display_name":"Thymoglobulin","level":4,"score":0.4323109984397888},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3973828852176666},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.3906025290489197},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3389834761619568},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3131951093673706},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2947533130645752},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.2610709071159363},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25200095772743225},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.2179698646068573},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.1829371154308319}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.2150.2150","doi":"https://doi.org/10.1182/blood.v112.11.2150.2150","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.2150.2150","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2555617200","https://openalex.org/W2582992809","https://openalex.org/W2030012469","https://openalex.org/W2074162968","https://openalex.org/W2565568893","https://openalex.org/W2554151643","https://openalex.org/W1974632374","https://openalex.org/W2535069021","https://openalex.org/W2135323960","https://openalex.org/W3095129285"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2,232,248,502,553],"combination":[3,543],"of":[4,10,50,75,90,100,117,155,196,251,274,295,315,339,349,377,396,515,532],"fludarabine":[5,41],"with":[6,20,35,42,67,130,289,325,341,389,500,511,525,550],"a":[7,30,45,60,81,96,113,272,512],"myeloablative":[8,26],"dose":[9,99,116,133,234,527],"busulfan":[11,528],"(FluBu4)":[12],"has":[13],"been":[14],"shown":[15],"to":[16,24,58,108,128,140,157,311,323,356,413,456,477,556],"be":[17,563],"well":[18,521],"tolerated":[19,522],"reduced":[21],"toxicity":[22],"compared":[23],"other":[25],"regimens.":[27],"Clofarabine":[28,519],"is":[29,506,520],"second":[31],"generation":[32],"purine":[33],"antimetabolite":[34],"potent":[36],"anti-leukemia":[37],"properties.":[38],"We":[39],"replaced":[40],"clofarabine":[43,111,156,233,324],"in":[44,55,85,170,286,303,308,420,425,435,452,492,529,548],"phase":[46],"I/":[47],"II":[48],"trial":[49,554],"Clofarabine-Busulfan":[51],"x":[52,104,124],"4":[53,227],"(CloBu4)":[54],"an":[56,290,335],"attempt":[57],"develop":[59],"pre-transplant":[61],"conditioning":[62,358],"regimen":[63,359],"suitable":[64],"for":[65,179,182,186,277,486,509],"pts":[66,79,146,167,176,210,269,398,437,450,464,482,490,499,538,549,558],"refractory,":[68],"non-remission":[69],"hematologic":[70,82],"malignancies":[71],"at":[72,87,271,494,565],"the":[73,88,131,138,153,331,357,566],"time":[74,89],"transplant.":[76,91],"Methods:":[77],"All":[78,145,266,537],"had":[80,211,379,399,443,451,473],"malignancy":[83],"not":[84],"remission":[86],"Busulfan":[92,282],"was":[93,164,253,301,433],"administered":[94],"as":[95,112],"single":[97,114],"daily":[98,115],"3.2":[101],"mg/kg":[102],"IV":[103,123,151],"4d":[105],"(days":[106,126],"-5":[107],"-2)":[109,129],"and":[110,168,184,205,226,243,280,306,327,344,372,407,422,470,541,559],"20,":[118],"30":[119,240],"or":[120,262],"40":[121,244],"mg/m2":[122,238,241],"5d":[125],"-6":[127],"specific":[132],"per":[134],"pt":[135,319,442],"determined":[136],"by":[137],"Time":[139],"Event-Continuous":[141],"Reassessment":[142],"Method":[143],"(TITE-CRM).":[144],"received":[147,212,334],"dexamethasone":[148,340],"12":[149],"mg":[150,338],"on":[152,392,438],"days":[154,276],"avoid":[158],"capillary":[159],"leak":[160],"syndrome.":[161],"GVHD":[162,418],"prophylaxis":[163],"tacrolimus/MMF":[165],"in19":[166],"tacrolimus/methotrexate":[169],"1.":[171],"Results:":[172],"To":[173],"date,":[174],"20":[175,237,337],"are":[177],"evaluable":[178,268,434],"toxicity,":[180],"19":[181,267],"engraftment,":[183],"16":[185],"response.":[187],"Diseases":[188],"were":[189,259,284,483,491],"AML":[190],"(including":[191],"2":[192,218,304,309],"myeloid":[193],"blast":[194],"crisis":[195],"CML)":[197],"(n=13),":[198],"ALL":[199],"(n=2),":[200,202,204],"CLL":[201],"NHL":[203],"multiple":[206],"myeloma":[207],"(n=1).":[208,247],"Six":[209],"previous":[213],"stem":[214],"cell":[215,431],"transplantation":[216],"(SCT),":[217],"auto":[219],"SCT":[220,223,411],"(range":[221,229,256],"between":[222],"295-1066":[224],"d)":[225],"allo":[228],"75\u20131002":[230],"d).":[231],"levels":[235],"were:":[236],"(n=6),":[239],"(n=13)":[242],"mg/":[245],"m2":[246],"median":[249,513],"age":[250],"patients":[252,288],"51":[254],"years":[255],"13\u201368).":[257],"Donors":[258],"siblings":[260],"(n=8)":[261],"unrelated":[263],"volunteers":[264],"(n=12).":[265],"engrafted":[270,539],"mean":[273],"11":[275],"both":[278],"neutrophils":[279],"platelets.":[281],"kinetics":[283],"evaluated":[285],"14":[287],"average":[291],"steady":[292],"state":[293],"level":[294],"803":[296],"ng/ml":[297],"(605\u20131132).":[298],"Dose":[299],"increase":[300],"required":[302],"cases":[305,310],"decrease":[307],"maintain":[312],"target":[313],"range":[314],"600\u2013900":[316],"ng/ml.":[317],"One":[318],"who":[320],"developed":[321,419],"hypersensitivity":[322],"fever":[326],"joint":[328],"pain":[329],"after":[330],"first":[332],"dose,":[333],"additional":[336],"subsequent":[342],"doses":[343,348],"finished":[345],"all":[346],"five":[347],"clofarabine.":[350],"Other":[351],"grade":[352],"3\u20134":[353],"toxicities":[354],"attributable":[355],"include":[360],"transient":[361],"liver":[362,393,404],"enzyme":[363],"abnormalities":[364],"(8/20),":[365],"hypoxia":[366],"(5/20),":[367],"hypertension":[368],"(2/20),":[369],"seizure":[370],"(1/20),":[371],"ascites":[373,378],"(2/20).":[374],"Neither":[375],"case":[376,384],"elevated":[380],"bilirubin,":[381],"but":[382],"one":[383,426],"showed":[385],"pathologic":[386],"findings":[387],"compatible":[388],"veno-occlusive":[390],"disease":[391,487],"biopsy.":[394],"Both":[395],"these":[397],"pre-existing":[400],"conditions":[401],"including":[402,497],"pretransplant":[403],"damage":[405],"(1)":[406],"enlarged":[408],"spleen":[409],"before":[410],"due":[412],"preceding":[414],"myelofibrosis":[415],"(1).":[416],"Acute":[417],"2/20":[421],"proved":[423],"fatal":[424],"case.":[427],"Peripheral":[428],"blood":[429],"CD3+":[430,446],"chimerism":[432,454,475],"10":[436,503],"day":[439,461,495],"30;":[440],"1":[441],"100%":[444],"donor":[445,467],"cells,":[447],"whereas":[448],"9":[449],"mixed":[453,474],"(<5%":[455,476],"29%":[457],"recipient":[458,479],"cells).":[459,480],"By":[460],"100,":[462],"5/10":[463],"achieved":[465],"complete":[466],"type":[468],"chimerism,":[469],"5":[471],"still":[472],"20%":[478],"Four":[481],"too":[484],"early":[485],"assessment;":[488],"11/16":[489],"CR":[493],"30,":[496],"9/11":[498],"AML.":[501],"months":[504],"OS":[505],"80%":[507],"(82%":[508],"AML)":[510],"follow-up":[514],"6":[516],"months.":[517],"Conclusion:":[518],"when":[523],"given":[524],"full":[526],"this":[530,542],"group":[531],"very":[533],"high":[534],"risk":[535],"pts.":[536],"rapidly,":[540],"shows":[544],"promising":[545],"anti-tumor":[546],"activity":[547],"relapsed/refractory":[551],"diseases.":[552],"continues":[555],"accrue":[557],"updated":[560],"results":[561],"will":[562],"presented":[564],"meeting.":[567],"Figure":[568,569]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-12-08T00:00:00"}